Selected research
Industry Growth & Trends
Global Glyburide Industry Growth and Trends Forecast to 2032
Market perspective
The global Glyburide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glyburide include Sunlight Pharmaceutical, Double Whale Pharmaceutical, Shapuaisi Pharma, Novartis, Jisheng Medicine, CR Sanjiu, Bohai Pharmaceutical, Sanofi Aventis and Physicians Total Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Glyburide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Glyburide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glyburide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glyburide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Glyburide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Glyburide Market by Company
Sunlight Pharmaceutical
Double Whale Pharmaceutical
Shapuaisi Pharma
Novartis
Jisheng Medicine
CR Sanjiu
Bohai Pharmaceutical
Sanofi Aventis
Physicians Total Care
Hoechst Canada
Hikma Pharmaceuticals
Dominion Pharmacal
Cadila Pharmaceuticals
Avanstra
Apotex Corporation
Amneal Pharmaceuticals
Glyburide Segment by Type
1.25mg
2.5mg
5mg
Glyburide Segment by Application
Pediatric Use
Geriatric Use
Others
Glyburide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glyburide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glyburide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glyburide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glyburide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glyburide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1.25mg
- 2.5mg
- 5mg
Applications
- Pediatric Use
- Geriatric Use
- Others
Companies covered
- Sunlight Pharmaceutical
- Double Whale Pharmaceutical
- Shapuaisi Pharma
- Novartis
- Jisheng Medicine
- CR Sanjiu
- Bohai Pharmaceutical
- Sanofi Aventis
- Physicians Total Care
- Hoechst Canada
- Hikma Pharmaceuticals
- Dominion Pharmacal
- Cadila Pharmaceuticals
- Avanstra
- Apotex Corporation
- Amneal Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glyburide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glyburide Sales Estimates and Forecasts (2021-2032)
- 1.3 Glyburide Market by Type
- 1.3.1 1.25mg
- 1.3.2 2.5mg
- 1.3.3 5mg
- 1.4 Global Glyburide Market Size by Type
- 1.4.1 Global Glyburide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Glyburide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Glyburide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Glyburide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Glyburide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Glyburide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Glyburide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Glyburide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Glyburide Industry Trends
- 2.2 Glyburide Industry Drivers
- 2.3 Glyburide Industry Opportunities and Challenges
- 2.4 Glyburide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Glyburide Revenue (2021-2026)
- 3.2 Global Top Players by Glyburide Sales (2021-2026)
- 3.3 Global Top Players by Glyburide Price (2021-2026)
- 3.4 Global Glyburide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glyburide Major Company Production Sites & Headquarters
- 3.6 Global Glyburide Company, Product Type & Application
- 3.7 Global Glyburide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glyburide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glyburide Players Market Share by Revenue in 2025
- 3.8.3 2025 Glyburide Tier 1, Tier 2, and Tier 3
4 Glyburide Regional Status and Outlook
- 4.1 Global Glyburide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Glyburide Historic Market Size by Region
- 4.2.1 Global Glyburide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Glyburide Sales in Value by Region (2021-2026)
- 4.2.3 Global Glyburide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Glyburide Forecasted Market Size by Region
- 4.3.1 Global Glyburide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Glyburide Sales in Value by Region (2027-2032)
- 4.3.3 Global Glyburide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glyburide by Application
- 5.1 Glyburide Market by Application
- 5.1.1 Pediatric Use
- 5.1.2 Geriatric Use
- 5.1.3 Others
- 5.2 Global Glyburide Market Size by Application
- 5.2.1 Global Glyburide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Glyburide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Glyburide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Glyburide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Glyburide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Glyburide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Glyburide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Glyburide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sunlight Pharmaceutical
- 6.1.1 Sunlight Pharmaceutical Company Information
- 6.1.2 Sunlight Pharmaceutical Business Overview
- 6.1.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sunlight Pharmaceutical Glyburide Product Portfolio
- 6.1.5 Sunlight Pharmaceutical Recent Developments
- 6.2 Double Whale Pharmaceutical
- 6.2.1 Double Whale Pharmaceutical Company Information
- 6.2.2 Double Whale Pharmaceutical Business Overview
- 6.2.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Double Whale Pharmaceutical Glyburide Product Portfolio
- 6.2.5 Double Whale Pharmaceutical Recent Developments
- 6.3 Shapuaisi Pharma
- 6.3.1 Shapuaisi Pharma Company Information
- 6.3.2 Shapuaisi Pharma Business Overview
- 6.3.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shapuaisi Pharma Glyburide Product Portfolio
- 6.3.5 Shapuaisi Pharma Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Glyburide Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 Jisheng Medicine
- 6.5.1 Jisheng Medicine Company Information
- 6.5.2 Jisheng Medicine Business Overview
- 6.5.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jisheng Medicine Glyburide Product Portfolio
- 6.5.5 Jisheng Medicine Recent Developments
- 6.6 CR Sanjiu
- 6.6.1 CR Sanjiu Company Information
- 6.6.2 CR Sanjiu Business Overview
- 6.6.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CR Sanjiu Glyburide Product Portfolio
- 6.6.5 CR Sanjiu Recent Developments
- 6.7 Bohai Pharmaceutical
- 6.7.1 Bohai Pharmaceutical Company Information
- 6.7.2 Bohai Pharmaceutical Business Overview
- 6.7.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bohai Pharmaceutical Glyburide Product Portfolio
- 6.7.5 Bohai Pharmaceutical Recent Developments
- 6.8 Sanofi Aventis
- 6.8.1 Sanofi Aventis Company Information
- 6.8.2 Sanofi Aventis Business Overview
- 6.8.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sanofi Aventis Glyburide Product Portfolio
- 6.8.5 Sanofi Aventis Recent Developments
- 6.9 Physicians Total Care
- 6.9.1 Physicians Total Care Company Information
- 6.9.2 Physicians Total Care Business Overview
- 6.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Physicians Total Care Glyburide Product Portfolio
- 6.9.5 Physicians Total Care Recent Developments
- 6.10 Hoechst Canada
- 6.10.1 Hoechst Canada Company Information
- 6.10.2 Hoechst Canada Business Overview
- 6.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Hoechst Canada Glyburide Product Portfolio
- 6.10.5 Hoechst Canada Recent Developments
- 6.11 Hikma Pharmaceuticals
- 6.11.1 Hikma Pharmaceuticals Company Information
- 6.11.2 Hikma Pharmaceuticals Business Overview
- 6.11.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Hikma Pharmaceuticals Glyburide Product Portfolio
- 6.11.5 Hikma Pharmaceuticals Recent Developments
- 6.12 Dominion Pharmacal
- 6.12.1 Dominion Pharmacal Company Information
- 6.12.2 Dominion Pharmacal Business Overview
- 6.12.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Dominion Pharmacal Glyburide Product Portfolio
- 6.12.5 Dominion Pharmacal Recent Developments
- 6.13 Cadila Pharmaceuticals
- 6.13.1 Cadila Pharmaceuticals Company Information
- 6.13.2 Cadila Pharmaceuticals Business Overview
- 6.13.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Cadila Pharmaceuticals Glyburide Product Portfolio
- 6.13.5 Cadila Pharmaceuticals Recent Developments
- 6.14 Avanstra
- 6.14.1 Avanstra Company Information
- 6.14.2 Avanstra Business Overview
- 6.14.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Avanstra Glyburide Product Portfolio
- 6.14.5 Avanstra Recent Developments
- 6.15 Apotex Corporation
- 6.15.1 Apotex Corporation Company Information
- 6.15.2 Apotex Corporation Business Overview
- 6.15.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Apotex Corporation Glyburide Product Portfolio
- 6.15.5 Apotex Corporation Recent Developments
- 6.16 Amneal Pharmaceuticals
- 6.16.1 Amneal Pharmaceuticals Company Information
- 6.16.2 Amneal Pharmaceuticals Business Overview
- 6.16.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Amneal Pharmaceuticals Glyburide Product Portfolio
- 6.16.5 Amneal Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Glyburide Sales by Country
- 7.1.1 North America Glyburide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Glyburide Sales by Country (2021-2026)
- 7.1.3 North America Glyburide Sales Forecast by Country (2027-2032)
- 7.2 North America Glyburide Market Size by Country
- 7.2.1 North America Glyburide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Glyburide Market Size by Country (2021-2026)
- 7.2.3 North America Glyburide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Glyburide Sales by Country
- 8.1.1 Europe Glyburide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Glyburide Sales by Country (2021-2026)
- 8.1.3 Europe Glyburide Sales Forecast by Country (2027-2032)
- 8.2 Europe Glyburide Market Size by Country
- 8.2.1 Europe Glyburide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Glyburide Market Size by Country (2021-2026)
- 8.2.3 Europe Glyburide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Glyburide Sales by Country
- 9.1.1 Asia-Pacific Glyburide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Glyburide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Glyburide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Glyburide Market Size by Country
- 9.2.1 Asia-Pacific Glyburide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Glyburide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Glyburide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Glyburide Sales by Country
- 10.1.1 South America Glyburide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Glyburide Sales by Country (2021-2026)
- 10.1.3 South America Glyburide Sales Forecast by Country (2027-2032)
- 10.2 South America Glyburide Market Size by Country
- 10.2.1 South America Glyburide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Glyburide Market Size by Country (2021-2026)
- 10.2.3 South America Glyburide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Glyburide Sales by Country
- 11.1.1 Middle East and Africa Glyburide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Glyburide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Glyburide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Glyburide Market Size by Country
- 11.2.1 Middle East and Africa Glyburide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Glyburide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Glyburide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Glyburide Value Chain Analysis
- 12.1.1 Glyburide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Glyburide Production Mode & Process
- 12.2 Glyburide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Glyburide Distributors
- 12.2.3 Glyburide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst